Share Prices & Company Research

Market News

30 Mar 2021 | 13:48

Fevertree slumps after RBC downgrade

(Sharecast News) - Fevertree slumped on Tuesday after RBC Capital Markets downgraded its stance on shares of the posh tonics maker to 'sector perform' from 'outperform' and slashed the price target from 2,600p. RBC said the US business is doing as well as it anticipated. However, the margin outlook has "significantly" deteriorated.

"Fevertree has already missed margin guidance five times in the last four years, and after exploring the moving parts, we are not sure FY21E margin guidance looks conservative," it said.

"Lower margin forecasts and a higher UK tax rate leave us with a 2,000 price target."

At 1400 BST, the shares were down 4.7% at 2,188p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.